Terminal differentiation of epithelial cells in middle ear cholesteatoma: Investigation of patterns of expression of protein kinase C-δ and protein kinase C-η

Laryngoscope

Volumn 109, Issue 11, 1999, Pages 1785-1792

  Miyazaki, Hidemi ^a   Kojima, Hiromi ^a   Tanaka, Yasuhiro ^a   Shiwa, Masanori ^a   Koga, Tomohiko ^b   Moriyama, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Social Insurance Hospital   (Japan)

Author keywords

Cholesteatoma; Cytokeratin 1; Cytokeratin 10; Involucrin; Protein kinase C delta; Protein kinase C eta; Terminal differentiation

Indexed keywords

CYTOKERATIN; INVOLUCRIN; PROTEIN KINASE C;

ARTICLE; CELL DIFFERENTIATION; CHOLESTEATOMA; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MIDDLE EAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; CELL DIFFERENTIATION; CHOLESTEATOMA, MIDDLE EAR; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION;

EID: 0032716444     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199911000-00012     Document Type: Article

References (29)

1. Tanaka Y, Shiwa M, Kojima H, et al. A study on epidermal proliferation ability in cholesteatoma. Laryngoscope 1998; 108:537-542.
2. Kojima H, Shiwa M, Moríyama H, et al. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol (Stockh) 1994;114:423-429.
3. Shiwa M, Kojima H, Morìyama H. Expression of transforming growth factor-α (TGF-α) in cholesteatoma. J Laryngol Otol 1998;112:756-754.
4. Bujia J, Schillíng V, Holly A, et al. Hyperproliferation associated keratin expression its human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993;113:364-368.
5. Sasaki H, Huang CC. Expression of cytokeratin 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1994;110:310-317.
6. Bujia J, Kim C, Boyle D, et al. Quantitative analysis of interluekin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope 1996;106:217-220.
7. Stammberger M, Bujia J, Kastenbauer E. Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol 1995;16:527-531.
8. Vennix PPCA, Kuijpers A, Peters TA, et. al. Keratinocyte differentiation in sequired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 1996;122:825-832.
9. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984; 308:693-698.
10. η, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 1990;265:22434-440.
11. Gherzi R, Sparatore B, Patrone M, et al. Protein kinase C mRNA levels and activity in reconstituted normal human epidermis: relationships to cell differentiation. Biochem Biophys Res Commun 1992;184:283-291.
12. Shinkawa H, Hozawa J, Usami S, et al. Immunohistochemical study on cytokeratin and vimentin expression in congenital cholesteatoma. In: Nakano Y, ed. Cholesteatoma and Mastoid Surgery. Niigata, Japan: Kugler & Ghedini, 1992:155-166.
13. Usami S, Shiskawa H. Immunocytochemical characterization of middle ear cholesteatoma. Otorhinolaryngol Tokyo 1995;38:582-589.
14. η, a Ca(2+)-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth Differ 1993;4:167-175.
15. Oishi K, Raynor RL, Charp PA, et al. Regulation of protein kinase C by lysophospholipids. J Biol Chem 1988;263: 6865-6871.
16. Fujii M. Growth suppression of squamous cell carcinoma cell lines by PKCs: possible application to gene therapy. J Stomatol Soc Jpn 1997;64:52-66.
17. Vennix PPCA, Kuijpers A, Tonnaer E, et al. Cytokeratin in induced epidermoid formation and cholesteatoma lesions. Arch Otolaryngol Head Neck Surg 1996;122:825-832.
18. Broekaert D, Cornille A, Etbo H, et al. A comparative immunocytochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Virchows Arch 1988;413:39-51.
19. Murphy G, Flynn T, Rice et al. Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dertmatol 1984;82:453-457.
20. Walts A, Said J. Involucrin, a marker of squamous and urothelial differentiation: an immunohistochemical study on its distribution in normal and neoplastic tissues. J Pathol 1985;145:329-340.
21. η, a Ca(2+)-independent protein kinase C, in normal human skin and skin diseases. J Invest Dermatol 1993;101:858-863.
22. Nonomura K, Yamanishi K, Hosokawa Y, et al. Localization of transghitaminase 1 mRNA in normal and psoriatic epidermis by nonradioactive in situ hybridization. Br J Dermatol 1993;128:23-28.
23. Dlugosz AA, Cheng C, Williams EK, et al. Alterations in murin keratinocyte differentiation iaduced by activated rasHA genes are mediated by protein kinase C-α. Cancer Res 1994;54:6413-6420.
24. Takahashi H, Asano K, Manabe A, et al. The α and η isoforms of protein kinase C stimulate transcription of human involucrin gene. J Invest Dermatol 1998;110:218-223.
25. Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptesis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998;124:261-264.
26. Kojima H, Miyazaki H, Tanaka Y, et al. Role of Bcl-xL for differentiation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1999;125:738-742.
27. Maruoka Y, Harada H, Mitsuyasu T, et al. Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 1997;238:886-890.
28. Harada H, Mitsuyasu T, Seta Y, et al. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vivo. J Oral Pathol Med 1998;27:11-17.
29. Kinoshita K. The roles of interleukin 1α, tumor necrosis factor-α and parathyroid hormone-related protein in bone resurption of cholesteatoma. J Otolaryngol Jpn 1994;97: 1472-1480.